Natera, Inc.
NASDAQ:NTRA
124.74 (USD) • At close October 29, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Natera, Inc. |
Symbool | NTRA |
Munteenheid | USD |
Prijs | 124.74 |
Beurswaarde | 15,427,967,940 |
Dividendpercentage | 0% |
52-weken bereik | 37.665 - 133.539 |
Industrie | Diagnostics & Research |
Sector | Healthcare |
CEO | Mr. Steven Leonard Chapman |
Website | https://www.natera.com |
An error occurred while fetching data.
Over Natera, Inc.
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify single-gene
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)